Jing Yi
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 10
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways 16
- Mitochondrial Function and Pathology 7
- Retinoids in leukemia and cellular processes 6
- Toxicology top 2%
- Oncology top 5%
- Cancer-related Molecular Pathways 7
- Immunology top 10%
- interferon and immune responses 5
-
- Catalytic Processes in Materials Science 10
-
- Catalysis and Oxidation Reactions 7
- Co-authors
- Jie YangKai YangCang HuiGuiying ShiYing WangYuying ChenXuxu SunYi Yang
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Jing Yi
77 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 892
- Molecular Biology 2.8k
- Toxicology 100
- Oncology 694
- Immunology 417
Countries citing papers authored by Jing Yi
This map shows the geographic impact of Jing Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Yi more than expected).
Fields of papers citing papers by Jing Yi
This network shows the impact of papers produced by Jing Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Yi. The network helps show where Jing Yi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 62 | |
| 2 | 2021 | 6 | |
| 3 | 2020 | 29 | |
| 4 | 2020 | 16 | |
| 5 | 2019 | 55 | |
| 6 | 2019 | 38 | |
| 7 | 2016 | 114 | |
| 8 | 2015 | 313 | |
| 9 | 2015 | 26 | |
| 10 | Expressions of farnesoid X receptor and myeloid cell leukemia sequence 1 protein are associated with poor prognosis in patients with gallbladder cancer. | 2014 | 10 |
| 11 | 2014 | 46 | |
| 12 | 2012 | 202 | |
| 13 | 2012 | 62 | |
| 14 | 2012 | 19 | |
| 15 | 2009 | 18 | |
| 16 | 2009 | 46 | |
| 17 | 2008 | 8 | |
| 18 | 2008 | 73 | |
| 19 | 2008 | 15 | |
| 20 | 2006 | 49 |
About Jing Yi
Jing Yi is a scholar working on Cancer Research, Catalysis, Process Chemistry and Technology, Molecular Biology and Oncology, having authored 77 papers that have together received 4.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (16 papers), Catalytic Processes in Materials Science (10 papers), Cancer, Hypoxia, and Metabolism (10 papers), Catalysis and Oxidation Reactions (7 papers), Cancer-related Molecular Pathways (7 papers), Mitochondrial Function and Pathology (7 papers), Retinoids in leukemia and cellular processes (6 papers) and interferon and immune responses (5 papers). The work is most often cited by research in Cancer Research (892 citations), Molecular Biology (2.8k citations), Toxicology (100 citations), Oncology (694 citations) and Immunology (417 citations). Jing Yi has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Jie Yang, Kai Yang, Cang Hui, Guiying Shi, Ying Wang, Yuying Chen, Xuxu Sun, Yi Yang, Yuzheng Zhao and Edward T.H. Yeh. Their work appears in journals such as Oncogene, Cell Metabolism, Nature Communications, Fuel and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.